He Zhongchun, Wang Zhaofei, Dong Bo, Long Qiuxiang
Department of Cardiovascular Internal Medicine, Changsha First Hospital, Changsha, China.
Department of Introduction, Changsha First Hospital, Changsha, China.
Anatol J Cardiol. 2025 Jan 7;29(3):132-8. doi: 10.14744/AnatolJCardiol.2024.4674.
This research aimed to investigate the clinical features exhibited by individuals diagnosed with acute myocardial infarction (AMI) complicated by ventricular septal rupture (VSR) and to compare the prognostic outcomes of different treatment modalities.
A retrospective study on a cohort of 200 patients who were diagnosed with AMI complicated by VSR at a specialized medical facility from 2018 to 2023 was conducted. The patients were categorized into 3 different treatment groups: group A received medical management, group B underwent surgical repair, and group C underwent percutaneous device closure. Our primary objective was to assess the overall mortality rate within 1 year, while secondary objectives included evaluating in-hospital mortality, mortality within 30 days, and occurrence of major adverse cardiovascular events within 1 year.
Group A showed the highest in-hospital mortality rate of 37.3%. The rate for group B was only 20.6%, while group C exhibited the lowest rate of 17.4%. A similar tendency was observed for the 30-day and 1-year mortality rates. The 30-day mortality rate for group A, group B, and group C was 56.9%, 20.6%, and 22.1%, respectively. The 1-year mortality rate for group A, group B, and group C was as follows: 31.4%, 28.6%, and 25.6%. In addition, the incidence of major adverse cardiovascular events at 1 year was highest in group A (56.9%), followed by group B (28.6%) and group C (32.6%).
Both surgical repair and percutaneous device closure were associated with significantly better survival outcomes compared to medical management alone in patients with AMI complicated by VSR.
本研究旨在调查诊断为急性心肌梗死(AMI)并发室间隔破裂(VSR)的个体所表现出的临床特征,并比较不同治疗方式的预后结果。
对2018年至2023年在一家专业医疗机构诊断为AMI并发VSR的200例患者进行了一项回顾性研究。患者被分为3个不同的治疗组:A组接受药物治疗,B组接受手术修复,C组接受经皮器械封堵。我们的主要目标是评估1年内的总死亡率,次要目标包括评估住院死亡率、30天内死亡率以及1年内主要不良心血管事件的发生率。
A组显示出最高的住院死亡率,为37.3%。B组的死亡率仅为20.6%,而C组的死亡率最低,为17.4%。在30天和1年死亡率方面也观察到了类似的趋势。A组、B组和C组的30天死亡率分别为56.9%、20.6%和22.1%。A组、B组和C组的1年死亡率如下:31.4%、28.6%和25.6%。此外,1年时主要不良心血管事件的发生率在A组最高(56.9%),其次是B组(28.6%)和C组(32.6%)。
在AMI并发VSR的患者中,与单纯药物治疗相比,手术修复和经皮器械封堵均与显著更好的生存结果相关。